Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.
Alice Rees initially put the pain under her ribs and nausea that she experienced while on holiday with friends in July 2023 ...
HPV causes irritating warts, or lesions, on the back, front, or side of the tongue. Males have a higher risk of developing ...
KEYTRUDA monotherapy is the recommended first-line treatment for recurrent or metastatic HNSCC with high PD-L1 expression, ...
Professor and surgeon Jason Hunt, MD, MS, FACS, has been named inaugural Chair of the Department of Otolaryngology – Head and ...
"The best part of the job is hopefully curing somebody of cancer and giving them back the life they and their family wouldn’t ...
The registrational trial will include 212 patients who are newly diagnosed with advanced head and neck cancer.
The Da Vinci SP made its way to the operating room for doctors at Trident Medical Center. The robot that uses a single port, ...
Robots in the operating room aren’t new but, for the Lowcountry, an upgrade in technology is boosting treatment in the head ...
Jennifer Alexander gets asked about her tattooed tongue every day, but she "couldn't be happier" with how it turned out and loves raising awareness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback